lovastatin

Statins are also found in the combination medications Advicor (lovastatin + niacin), Caduet (atorvastatin + amlodipine) and Vytorin (simvastatin + ezetimibe).

Kos' two most prominent drugs in the segment are Niaspan, an extended-release tablet that raises HDL (good cholesterol), and Advicor, another extended-release tablet that treats multiple lipid disorders.

Glickman was responsible for the launch of ADVICOR, the second commercial product for Kos.

The copromotion agreement provides that Kos and Duramed Pharmaceuticals, a subsidiary of Barr, will copromote the current Niaspan and Advicor products--as well as future dosage formulations, strengths or modified versions of those products--to obstetricians, gynecologists and other practitioners with a focus on women's health care in the U.

Niaspan and Advicor are registered trademarks of Kos Life Sciences LLC.

alleging the latter has infringed on a patent covering unique features for Niaspan and Advicor for the treatment of cholesterol disorders.

The Company currently markets Niaspan, Advicor, Azmacort, Cardizem LA, Teveten and Teveten HCT.

KOSP's products include Niaspan for the treatment of mixed lipid disorders; Advicor for the treatment of primary hypercholeterolimia and mixed dyslipidemia in patients previously treated with either component or who require additional lipid modification; and Azmacort product, an inhaled corticosteroid that alleviates inflammation in the lungs and is used as a treatment for asthma.